# OnCo record nct05797831 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05797831/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05797831", "NCT05797831" ;
  schema:name "Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer"@en ;
  schema:description "A phase 2/3 trial of KRT-232 in endometrial cancer, run by Kartos Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05797831/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05797831> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2023-07-17" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/> ;
  onco:drugs <https://onco.cc/drugs/krt-232/> ;
  onco:companies <https://onco.cc/companies/kartos-therapeutics/> .